On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

MCCC1

methylcrotonyl-CoA carboxylase subunit 1

The *MCCC1* gene provides instructions for a crucial enzyme subunit involved in the breakdown of amino acids, particularly leucine, within the mitochondria. The *MCCC1* gene encodes the alpha subunit of the 3-methylcrotonyl-CoA carboxylase (MCC) enzyme, which plays an essential role in protein metabolism.

Chromosome 3q27.1 Autosomal recessive HGNC:6936 Tier C
MCCC1 3q27.1 p arm q arm 3

MCCC1 is located on the long (q) arm of chromosome 3, at band 3q27.1. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 3 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The *MCCC1* gene, also known as methylcrotonyl-CoA carboxylase subunit 1, is vital for cellular metabolism. It carries the genetic blueprint for a component of the 3-methylcrotonyl-CoA carboxylase (MCC) enzyme, which is active in the mitochondria, the cell's energy-producing organelles. This enzyme is primarily involved in breaking down proteins obtained from food.

Dysfunction of the *MCCC1* gene can result in impaired protein processing, specifically affecting the metabolism of the amino acid leucine. Such impairments are characteristic of 3-methylcrotonyl-CoA carboxylase deficiency, an inherited metabolic condition.

What the gene does

The *MCCC1* gene produces the alpha subunit of the 3-methylcrotonyl-CoA carboxylase (MCC) enzyme. Six of these alpha subunits combine with six smaller beta subunits, encoded by the *MCCC2* gene, to form a fully functional MCC enzyme complex. The alpha subunit also contains a binding site for biotin, a B vitamin, which is essential for the enzyme's activity.

Located within the mitochondria, the MCC enzyme is critical for the breakdown of proteins. Specifically, it performs the fourth step in the catabolism of leucine, an essential amino acid. This enzymatic reaction converts 3-methylcrotonyl-CoA into 3-methylglutaconyl-CoA, which then undergoes further chemical transformations to produce molecules used for energy generation within the cell. Without a properly functioning MCC enzyme, the body cannot efficiently process leucine, leading to a build-up of potentially harmful substances.

Video: Genetics 101

Chromosome location

The *MCCC1* gene is located on chromosome 3, specifically at position 3q27.1. This precise genomic address helps in mapping and understanding the gene's physical location within the human genome.

Protein structure

The *MCCC1* gene encodes a protein composed of 725 amino acids. This protein contains several functional regions crucial for its role in metabolism. Key domains include the Biotin carboxylation domain, spanning amino acids 48 to 494, which is responsible for the enzymatic carboxylase activity. Additionally, an ATP-grasp domain is found between amino acids 167 and 364, involved in ATP binding. The protein also features a Biotinyl-binding domain from amino acids 643 to 715, which facilitates the attachment of biotin, a necessary cofactor for the enzyme's function.

Domain map · 725 amino acids
Biotin carboxylation (48–494)ATP-grasp (167–364)Biotinyl-binding (643–715)Biotin carboxylation48–494ATP-grasp167–364Biotinyl-binding643–7151~363725
Domain - independent functional unit
🧬 Explore 3D structure on AlphaFold
UniProt:Q96RQ3Length:725 aaStructure:AlphaFold

Key variants

Variants, also referred to as mutations, in the *MCCC1* gene can alter the protein it produces, potentially affecting the function of the 3-methylcrotonyl-CoA carboxylase enzyme. These genetic changes can range from single amino acid substitutions to alterations that lead to the production of shortened or non-functional proteins. The specific impact of a variant often depends on its location and the nature of the genetic change.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for MCCC1.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1126del
Deletion
p.Thr376fs Pathogenic/Likely pathogenic ★★☆☆ 3-methylcrotonyl-CoA carboxylase 1 deficiency
c.1378-2A>G
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ 3-methylcrotonyl-CoA carboxylase 1 deficiency
c.1518del
Deletion
p.Glu506fs Pathogenic/Likely pathogenic ★★☆☆ 3-methylcrotonyl-CoA carboxylase 1 deficiency
c.1541dup
Duplication
p.Leu515fs Pathogenic/Likely pathogenic ★★☆☆ 3-methylcrotonyl-CoA carboxylase 1 deficiency
c.1630del
Deletion
p.Arg544fs Pathogenic/Likely pathogenic ★★☆☆ 3-methylcrotonyl-CoA carboxylase 1 deficiency
c.1663_1664dup
Microsatellite
p.Lys556fs Pathogenic/Likely pathogenic ★★☆☆ 3-methylcrotonyl-CoA carboxylase 1 deficiency
c.1679del
Deletion
p.Asn560fs Pathogenic/Likely pathogenic ★★☆☆ 3-methylcrotonyl-CoA carboxylase 1 deficiency
c.1731+1del
Deletion
- Pathogenic/Likely pathogenic ★★☆☆ 3-methylcrotonyl-CoA carboxylase 1 deficiency
c.1750C>T
single nucleotide variant
p.Gln584Ter Pathogenic ★★☆☆ 3-methylcrotonyl-CoA carboxylase 1 deficiency
c.622del
Deletion
p.Arg208fs Pathogenic/Likely pathogenic ★★☆☆ 3-methylcrotonyl-CoA carboxylase 1 deficiency

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the *MCCC1* gene are the primary genetic cause of 3-methylcrotonyl-CoA carboxylase deficiency. This is an inherited metabolic disorder characterised by the body's inability to properly break down certain proteins, particularly the amino acid leucine. The condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of an altered *MCCC1* gene (one from each parent) to develop the disorder.

Inheritance pattern

Conditions caused by pathogenic MCCC1 variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous MCCC1 carrier status across ancestry groups?

UK clinical status

The *MCCC1* gene is included in several UK NHS national genomic testing panels, indicating its recognised clinical significance. It is featured on the DDG2P panel, the Intellectual disability panel, the Likely inborn error of metabolism panel (R98), and the Undiagnosed metabolic disorders panel.

Frequently asked questions

What is the main function of the MCCC1 gene?

The *MCCC1* gene provides instructions for making the alpha subunit of the 3-methylcrotonyl-CoA carboxylase (MCC) enzyme. This enzyme is crucial for breaking down the amino acid leucine within the mitochondria, an important step in protein metabolism.

What condition is associated with variants in the MCCC1 gene?

Variants in the *MCCC1* gene are associated with 3-methylcrotonyl-CoA carboxylase deficiency. This inherited metabolic disorder affects the body's ability to process certain proteins, specifically leading to issues with leucine breakdown.

How is 3-methylcrotonyl-CoA carboxylase deficiency inherited?

3-methylcrotonyl-CoA carboxylase deficiency is inherited in an autosomal recessive pattern. This means that a person must inherit two copies of the altered *MCCC1* gene, one from each parent, to develop the condition.

References

  1. Stadler SC, Polanetz R, Maier EM. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Human mutation. 2006. PMID: 16835865
  2. Dantas MF, Suormala T, Randolph A. 3-Methylcrotonyl-CoA carboxylase deficiency: mutation analysis in 28 probands, 9 symptomatic and 19 detected by newborn screening. Human mutation. 2005. PMID: 16010683
  3. Desviat LR, Pérez-Cerdá C, Pérez B. Functional analysis of MCCA and MCCB mutations causing methylcrotonylglycinuria. Molecular genetics and metabolism. 2003. PMID: 14680978
  4. Gallardo ME, Desviat LR, Rodríguez JM. The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolism. American journal of human genetics. 2001. PMID: 11170888
  5. Baumgartner MR, Almashanu S, Suormala T. The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. The Journal of clinical investigation. 2001. PMID: 11181649
  6. Obata K, Fukuda T, Morishita R. Human biotin-containing subunit of 3-methylcrotonyl-CoA carboxylase gene (MCCA): cDNA sequence, genomic organization, localization to chromosomal band 3q27, and expression. Genomics. 2001. PMID: 11401427
  7. Holzinger A, Röschinger W, Lagler F. Cloning of the human MCCA and MCCB genes and mutations therein reveal the molecular cause of 3-methylcrotonyl-CoA: carboxylase deficiency. Human molecular genetics. 2001. PMID: 11406611
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 27 September 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .